Pilot Grants Awarded to Teams Exploring How Breast Cancer Develops

Four innovative pilot grants were awarded for research projects investigating how breast cancer develops.

Dr. Susan Love Research Foundation awarded four pilot grants to research projects that will study the human breast and how it develops cancer with next generation technology. Three of the pilot grants, awarded at Dr. Susan Love Research Foundation’s 8th International Symposium on the Breast, are funded by the Susan G. Komen breast cancer organization. The fourth is funded by Atossa Genetics.

Technological advances have opened the door and created opportunities for researchers to explore new theories and directions, such as the microbiome of the breast and the relationship between the anatomy of the breast and cancer risk.

In 2015, Susan G. Komen and Atossa Genetics partnered with Dr. Susan Love Research Foundation to fund $50,000 in pilot grants and a single $20,000 award, respectively, to research collaborations formed during the Symposium.

“This is a tremendously exciting approach to granting that fosters the innovative thinking and scientific collaboration that are critical for the future of breast cancer research,” said Komen President and CEO Judith A. Salerno, MD, MS, who awarded the 2015 Pilot Grants. “We expect great results from these teams about this fundamental question: How does breast cancer develop?”

The grants will explore immune profiling of benign breast disease, optical coherence tomography for breast, intraductal therapy and prevention of breast cancer: de-jamming, and TLR5 agonist antitumor immunity.

With its unique approach to multidisciplinary collaboration, the International Symposium on the Breast attracts innovative clinical researchers, advocates, and basic scientists, and challenges them to collaborate on research projects that explore the cause and prevention of breast cancer.

“This Symposium is a unique assembly of many of the best minds in breast cancer research. Our approach to multidisciplinary collaborations inspires the exploration of ideas that may be too novel or preliminary for traditional funding mechanisms,” said Dr. Susan Love.

Source: Dr. Susan Love Research Foundation

Last updated: 3/24/15; 4:00pm EST

Check Also

FDA Approves Gavreto for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …

Leave a Reply

Your email address will not be published. Required fields are marked *